“…Increased serum CRP levels have been reported in subjects with obesity, metabolic syndrome, and type 2 diabetes (T2D), indicating that these individuals present a state of subclinical, low-grade inflammation that promotes the development of atherosclerosis mediated by a process of endothelial dysfunction, increasing the risk of ischemic heart disease (Wee et al, 2008;Hu et al, 2009). Serum CRP levels vary widely among individuals and, in the absence of disease, are influenced by socio-demographic factors, lifestyle, and significantly, gender, and obesity (Flores-Alfaro et al, 2008;Wee et al, 2008;Tsai and Tsai, 2010).…”